Cargando…

Pathogenic T-Cell Responses in Immune-Mediated Glomerulonephritis

Glomerulonephritis (GN) comprises a group of immune-mediated kidney diseases affecting glomeruli and the tubulointerstitium. Glomerular crescent formation is a histopathological characteristic of severe forms of GN, also referred to as crescentic GN (cGN). Based on histological findings, cGN include...

Descripción completa

Detalles Bibliográficos
Autores principales: Linke, Alexandra, Tiegs, Gisa, Neumann, Katrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139939/
https://www.ncbi.nlm.nih.gov/pubmed/35626662
http://dx.doi.org/10.3390/cells11101625
_version_ 1784714978199076864
author Linke, Alexandra
Tiegs, Gisa
Neumann, Katrin
author_facet Linke, Alexandra
Tiegs, Gisa
Neumann, Katrin
author_sort Linke, Alexandra
collection PubMed
description Glomerulonephritis (GN) comprises a group of immune-mediated kidney diseases affecting glomeruli and the tubulointerstitium. Glomerular crescent formation is a histopathological characteristic of severe forms of GN, also referred to as crescentic GN (cGN). Based on histological findings, cGN includes anti-neutrophil cytoplasmic antibody (ANCA)-associated GN, a severe form of ANCA-associated vasculitis, lupus nephritis associated with systemic lupus erythematosus, Goodpasture’s disease, and IgA nephropathy. The immunopathogenesis of cGN is associated with activation of CD4(+) and CD8(+) T cells, which particularly accumulate in the periglomerular and tubulointerstitial space but also infiltrate glomeruli. Clinical observations and functional studies in pre-clinical animal models provide evidence for a pathogenic role of Th1 and Th17 cell-mediated immune responses in cGN. Emerging evidence further argues that CD8(+) T cells have a role in disease pathology and the mechanisms of activation and function of recently identified tissue-resident CD4(+) and CD8(+) T cells in cGN are currently under investigation. This review summarizes the mechanisms of pathogenic T-cell responses leading to glomerular damage and renal inflammation in cGN. Advanced knowledge of the underlying immune mechanisms involved with cGN will enable the identification of novel therapeutic targets for the replacement or reduction in standard immunosuppressive therapy or the treatment of refractory disease.
format Online
Article
Text
id pubmed-9139939
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91399392022-05-28 Pathogenic T-Cell Responses in Immune-Mediated Glomerulonephritis Linke, Alexandra Tiegs, Gisa Neumann, Katrin Cells Review Glomerulonephritis (GN) comprises a group of immune-mediated kidney diseases affecting glomeruli and the tubulointerstitium. Glomerular crescent formation is a histopathological characteristic of severe forms of GN, also referred to as crescentic GN (cGN). Based on histological findings, cGN includes anti-neutrophil cytoplasmic antibody (ANCA)-associated GN, a severe form of ANCA-associated vasculitis, lupus nephritis associated with systemic lupus erythematosus, Goodpasture’s disease, and IgA nephropathy. The immunopathogenesis of cGN is associated with activation of CD4(+) and CD8(+) T cells, which particularly accumulate in the periglomerular and tubulointerstitial space but also infiltrate glomeruli. Clinical observations and functional studies in pre-clinical animal models provide evidence for a pathogenic role of Th1 and Th17 cell-mediated immune responses in cGN. Emerging evidence further argues that CD8(+) T cells have a role in disease pathology and the mechanisms of activation and function of recently identified tissue-resident CD4(+) and CD8(+) T cells in cGN are currently under investigation. This review summarizes the mechanisms of pathogenic T-cell responses leading to glomerular damage and renal inflammation in cGN. Advanced knowledge of the underlying immune mechanisms involved with cGN will enable the identification of novel therapeutic targets for the replacement or reduction in standard immunosuppressive therapy or the treatment of refractory disease. MDPI 2022-05-12 /pmc/articles/PMC9139939/ /pubmed/35626662 http://dx.doi.org/10.3390/cells11101625 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Linke, Alexandra
Tiegs, Gisa
Neumann, Katrin
Pathogenic T-Cell Responses in Immune-Mediated Glomerulonephritis
title Pathogenic T-Cell Responses in Immune-Mediated Glomerulonephritis
title_full Pathogenic T-Cell Responses in Immune-Mediated Glomerulonephritis
title_fullStr Pathogenic T-Cell Responses in Immune-Mediated Glomerulonephritis
title_full_unstemmed Pathogenic T-Cell Responses in Immune-Mediated Glomerulonephritis
title_short Pathogenic T-Cell Responses in Immune-Mediated Glomerulonephritis
title_sort pathogenic t-cell responses in immune-mediated glomerulonephritis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139939/
https://www.ncbi.nlm.nih.gov/pubmed/35626662
http://dx.doi.org/10.3390/cells11101625
work_keys_str_mv AT linkealexandra pathogenictcellresponsesinimmunemediatedglomerulonephritis
AT tiegsgisa pathogenictcellresponsesinimmunemediatedglomerulonephritis
AT neumannkatrin pathogenictcellresponsesinimmunemediatedglomerulonephritis